Genmab — Juni 2023
-
Så meget sparede hæmatologiske afdelinger sidste år på patentudløb på Revlimid https://haematologisktidsskrift.dk/samfund/1184-sa-meget-sparede-haematologiske-afdelinger-sidste-ar-pa-patentudlob-pa-revlimid.html
-
-
Det er nævnt lidt længere nede, har ikke adgang til fuld artikel, så h
er er kun overskrift: Novo Nordisk starter endnu et fase 3-studie med Genmab-udviklet blødermiddel
Et nyt fase 3-studie skal teste, hvor sikkert det er at skifte fra Roches blockbuster-blødermiddel til Novo Nordisks og Genmabs potentielt kommende ditto. -
Godmorgen

-
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons https://www.proinvestor.com/investornyt/994964/transactions-with-shares-and-linked-securities-in-genmab-a-s-made-by-managerial-employees-and-their-closely-associated-persons
-
Medico/biotek bliver vist fortsat holdt ude fra festen.
-
Så er det jo godt, at de gør det grundigt

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind